| |
Evidence Base
- Background
- Portfolio Optimisation / Divestment
- Business Development / Acquisition
- Key Modules
- Value Add
Portfolio Management
Business Development / M+A
Strategic Consultancy
RX - OTC Switch
Strategic Partnerships
- Market Analysis
- Regulatory Advisory
 |
EVIDENCE BASE
Business Development / Acquisition
This uses the same source data i.e. sales audit, historical investment and
consumer diagnostics. It is delivered as a series of integrated financial
modules allowing instant valuation and assimilation of any selected
acquisition target across any combination of category / geography.
Evidence Base can instantly quantify the portfolio impact of any
combination of target companies or brands, as well as identify and
prioritise company divestment and acquisition partners, on the
basis of defined strategic objectives.
The ability exists to instantly assess the impact of combining companies in terms of scale, portfolio
balance, category share, growth, antitrust issues etc. and can be instantly performed for any
combination of brand / corporation.
Whether buy side or sell side, this has significant benefit for
corporate / financial sponsors as a means of determining fit,
synergy and future development values.
Evidence Base is delivered in a fully automated, fully loaded,
client bespoke P+L format, with integral Cash Flow, NPV and
IRR analysis.
There is also a facility to run instant "what if" scenarios on key parameters including purchase
multiple, hurdle rate, A+P investment levels, A+P mix, sales growth and detailed costs synergies,
to view these outputs at regional, country and consolidated corporate levels.
Multinational analyses can also be run to forecast Switch, Geo expansion and NPD opportunities
vs. any given target company or brand. In an acquisition context, Evidence Base can therefore
be deployed at all phases.
|
|